OakChart

Agilent Technologies Inc

AHealthcare·Diagnostics & Research·USA·Large·NYSE·Nov 11 • 8:05 AM ET

178.00+0.12 (0.07%)
2026-11-11 14:13 CET
Market cap
50,149.53 USD m
Revenue, TTM
7,372.00 USD m
Net income, TTM
1,440.00 USD m
Free cash flow, TTM
1,267.00 USD m
EPS diluted, TTM
5.08
P/E
35.05
Compare

Price

A against its 20, 50 and 200-day averages
2050200missearnings
120.00140.00160.00180.003.3M6.5MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26Aclose 178.0020-day 175.7250-day 167.49200-day 137.57178.00

2.7% under 182.99 on 28 Oct 2026. Last 15 sessions, 7.7% high to low

Profile

A
52-week range, 93% of the way up
108.35182.99

Agilent Technologies, Inc. engages in the provision of application focused solutions for life sciences, diagnostics, and applied chemical markets. It operates through the following segments: Life Sciences and Diagnostics Markets, Applied Markets, and Agilent CrossLab. The Life Sciences and Diagnostics Markets segment offers active pharmaceutical ingredients for oligo-based therapeutics as well as solutions that include reagents, instruments, software and consumables. The Applied Markets segment refers to the application-focused solutions that include instruments and software that enable customers to identify, quantify, and analyze the physical and biological properties of substances and products. The Agilent CrossLab segment spans the entire lab with its extensive services and consumables portfolio in addition to software and laboratory automation solutions. The company was founded in May 1999 and is headquartered in Santa Clara, CA.

IndexS&P 500, RUI
Employees18100
IPONov 18, 1999
Beta1.23
ATR, 14d4.90
Rel volume0.00
Short float1.74%
Insider own0.32%
Inst own95.73%

Snapshot

6 groups

Valuation

IndexS&P 500, RUI
Market Cap50.18B
Enterprise Value52.37B
Income1.44B
Sales7.37B
Book/sh26.11
Cash/sh6.24
Dividend Est.1.02 (0.57%)
Dividend TTM1.02 (0.57%)
Dividend Ex-DateOct 06, 2026
Dividend Gr. 3/5Y5.63% 6.58%
Payout21.70%
Employees18100
IPONov 18, 1999

Ratios

P/E35.05
Forward P/E26.57
PEG2.69
P/S6.81
P/B6.82
P/C28.55
P/FCF39.61
EV/EBITDA25.59
EV/Sales7.10
Quick Ratio1.56
Current Ratio2.05
Debt/Eq0.54
LT Debt/Eq0.50
Option/ShortYes / Yes

Earnings

EPS (ttm)5.08
EPS next Y6.70
EPS next Q1.73
EPS this Y10.94%
EPS next Y8.04%
EPS next 5Y9.88%
EPS past 3/5Y3.03% 14.68%
Sales past 3/5Y0.48% 5.41%
EPS Y/Y TTM19.07%
Sales Y/Y TTM8.60%
EPS Q/Q8.50%
Sales Q/Q8.06%
EarningsNov 23 AMC
EPS/Sales Surpr.8.85% 1.98%

Ownership

Insider Own0.32%
Insider Trans-0.25%
Inst Own95.73%
Inst Trans-0.46%
ROA11.00%
ROE20.97%
ROIC13.08%
Gross Margin53.72%
Oper. Margin24.09%
Profit Margin19.53%
SMA201.30%
SMA506.28%
SMA20029.39%
Trades-

Technical

Shs Outstand281.97M
Shs Float281.04M
Short Float1.74%
Short Ratio2.14
Short Interest4.89M
52W High182.99 -2.73%
52W Low108.35 64.28%
Volatility3.00% 2.95%
ATR (14)4.90
RSI (14)56.10
Beta1.23
Rel Volume0.00
Avg Volume2.28M
Volume509

Performance

Perf Week0.47%
Perf Month3.73%
Perf Quarter19.23%
Perf Half Y57.89%
Perf YTD30.82%
Perf Year19.13%
Perf 3Y64.10%
Perf 5Y12.10%
Perf 10Y283.87%
Recom1.84
Target Price184.11
Prev Close177.88
Price178.00
Change %0.07%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Oct 26, 2026InitiatedDDeutsche BankBuy$190+6.7%
Sep 09, 2026ResumedUUBSNeutral$165-7.3%
Jul 09, 2026ResumedJJefferiesHold$135-24.2%
Jun 26, 2026ResumedBBernsteinOutperform$155-12.9%
Jun 11, 2026InitiatedPPiper SandlerNeutral$150-15.7%
May 28, 2026UpgradeBBofA SecuritiesNeutral → Buy$145-18.5%
May 27, 2026InitiatedRRBC Capital MktsOutperform$153-14.0%
Jan 20, 2026InitiatedHHSBC SecuritiesBuy$180+1.1%
Jan 05, 2026UpgradeEEvercore ISIIn-line → Outperform$160-10.1%
Dec 15, 2025UpgradeBBarclaysEqual Weight → Overweight$165-7.3%

Peers

Mkt cap
TickerCompanyMkt cap
WATWaters Corp46.74B
TMOThermo Fisher Scientific Inc265.76B
DHRDanaher Corp165.12B
MTDMettler-Toledo International Inc34.84B
RVTYRevvity Inc17.74B
QGENQiagen NV10.39B
BRKRBruker Corp9.58B
ILMNIllumina Inc32.96B
BIOBio-Rad Laboratories Inc10.41B
AVTRAvantor Inc10.55B

Insider trading

13 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Dolsten MikaelDirectorSep 04 '26Sale151.3863495,9724,924Sep 09 04:01 PM
Dolsten MikaelDirectorSep 04 '26Proposed Sale151.3863495,972Sep 04 04:19 PM
Dolsten MikaelDirectorMay 29 '26Sale135.421,600216,6725,548Jun 02 04:01 PM
Dolsten MikaelDirectorMay 29 '26Proposed Sale135.421,600216,672May 29 04:45 PM
Dolsten MikaelDirectorDec 01 '25Sale149.812,600389,5114,973Dec 03 04:04 PM
Gonsalves RodneyV.P., Corporate ControllerNov 26 '25Sale154.993,000464,95631,846Dec 01 04:29 PM
Dolsten MikaelDirectorDec 01 '25Proposed Sale149.812,600389,510Dec 01 04:26 PM
Gonsalves RodneyOfficerNov 26 '25Proposed Sale154.993,000464,956Nov 26 02:26 PM
MCDONNELL PADRAIGPresident and CEONov 18 '25Sale143.24911130,49232,058Nov 20 05:22 PM
MCDONNELL PADRAIGOfficerNov 18 '25Proposed Sale143.24911130,492Nov 18 10:37 AM
MCDONNELL PADRAIGPresident and CEONov 12 '25Option Exercise109.8612,4901,372,15145,938Nov 14 04:02 PM
MCDONNELL PADRAIGPresident and CEONov 12 '25Sale150.0012,4901,873,50033,448Nov 14 04:02 PM
MCDONNELL PADRAIGOfficerNov 12 '25Proposed Sale150.0012,4901,873,500Nov 12 10:03 AM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 689.41B
VOOVanguard S&P 500 ETFAUM: 1057.81B
VOVanguard Morningstar Mid-Cap ETFAUM: 107.70B
IVViShares Core S&P 500 ETFAUM: 875.00B
SPYSPDR S&P 500 ETF TrustAUM: 791.88B
VTVVanguard Morningstar Value ETFAUM: 195.79B
VOTVanguard Morningstar Mid-Cap Growth ETFAUM: 18.70B
XLVState Street Health Care Select Sector SPDR ETFAUM: 50.54B
VIGVanguard Dividend Appreciation FTFAUM: 116.72B
RSPInvesco S&P 500 Equal Weight ETFAUM: 104.22B

News

latest 14 of 206
  • Agilent Expands Tumor Profiling Portfolio with SureSelect Cancer Research Pan Heme (Business Wire)
  • Agilent Completes Acquisition of Proscia (Business Wire)
  • Revvity Inc. stock outperforms competitors on strong trading day (MarketWatch)
  • Agilent Launches 5987A MSD with GC Assist for Faster, Smarter GC/MS Workflows (Business Wire)
  • Agilent to Announce Fourth-Quarter Fiscal Year 2026 Financial Results on Nov. 23 (Business Wire)
  • Loading…
  • Breakout Watch: 4 Reasons To Monitor This Top-Rated Medical Stock (Investor's Business Daily)
  • Agilent and University of Chicago Launch Center of Excellence for Energy Materials Research (Business Wire)
  • Keysight Technologies Inc. stock underperforms Thursday when compared to competitors (MarketWatch)
  • Agilent acquires Proscia in deal worth up to $270m (Medical Device Network)
  • Agilent to buy Proscia for $240M (MedTech Dive)
  • Agilent to buy pathology software maker Proscia for $240 million (Reuters)
  • Agilent to Acquire Proscia, Advancing AI-Enabled Digital Pathology and Scientific Intelligence (Business Wire)
  • Agilent Introduces the NovoStation Sample Preparation System for Automated Flow Cytometry Workflows (Business Wire)

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q42026-11-23-1.727--1,98919
2026Q32026-08-261.6201.4881.2801,8781,84218
2026Q22026-05-271.4901.4081.1981,8351,79916
2026Q12026-02-251.3601.3701.0741,7981,80818
2025Q42025-11-241.5901.5841.5281,8391,83216
2025Q32025-08-271.3701.3681.1791,7381,68517
2025Q22025-05-281.3101.2650.7541,6681,62718
2025Q12025-02-261.3101.2811.1081,6551,67017
2024Q42024-11-251.4601.4101.2231,6911,67318
2024Q32024-08-211.3201.2590.9691,5781,55717
2024Q22024-05-291.2201.1911.0511,5731,58216
2024Q12024-02-271.2901.2251.1841,6581,58716
2023Q42023-11-201.3801.3431.6211,6881,66816
2023Q32023-08-151.4301.3650.3761,6721,66018
2023Q22023-05-231.2701.2641.0171,7141,68317
2023Q12023-02-281.3701.3121.1851,7541,70017

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY3.1103.0853.3685,1635,128
2020FY3.2803.2382.3055,3395,257
2021FY4.3404.3133.9416,3056,317
2022FY5.2205.0704.1806,8366,760
2023FY5.4405.4094.1896,8336,819
2024FY5.2905.2394.4306,5006,481
2025FY5.5905.5734.5706,8346,919
2026FY-6.202--7,500
2027FY-6.700--7,987
2028FY-7.416--8,510
2029FY-8.264--9,077
2030FY-9.100--9,705

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-1017001,9891,9761,997
2026Q4S2026-10-2317601,9891,9761,997
2026Q4S2026-10-0616601,9891,9761,997
2026Q4S2026-09-2816601,9891,9761,997
2026Q4S2026-09-2517701,9891,9761,997
2026Q4S2026-09-2317701,9891,9761,997
2026Q4S2026-09-0817801,9891,9761,997
2026Q4S2026-09-0116801,9891,9761,997
2026Q4S2026-08-2716801,9891,9761,997
2026Q4S2026-08-2615001,9711,9541,991
2026Q4S2026-08-2015001,9711,9541,991
2026Q4S2026-08-1215001,9711,9541,991
2026Q4S2026-07-1015101,9711,9541,991
2026Q4S2026-07-0715101,9701,9541,991

Estimate history

EPS, annual2.10.9723.3682.3053.9414.184.1894.434.5725.0791
Period201720182019202020212022202320242025TTM
EPS, quarterly0.9691.2231.1080.7541.1791.5281.0741.1981.279
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual4472491451635339631968486833651069487372
Period201720182019202020212022202320242025TTM
Sales, quarterly157817011681166817381861179818351878
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual322317.715309.071306.198302.208295.259292.123285.193283.054281.966
Period201720182019202020212022202320242025MRQ
Shares, quarterly287.53285.193285.232283.936283.594283.054282.696282.218281.966
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue7,372.006,948.006,510.006,833.006,848.006,319.005,339.005,163.004,914.00
Cost of Goods Sold Incl. D&A3,412.003,300.002,951.003,114.003,162.002,896.002,503.002,369.002,231.00
Gross Profit3,960.003,648.003,559.003,719.003,686.003,423.002,836.002,794.002,683.00
Selling, General and Administrative Excl. Other2,184.002,084.001,966.002,091.002,104.002,056.001,881.001,860.001,776.00
Research and Development480.00450.00452.00481.00467.00441.00397.00404.00387.00
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income1,776.001,564.001,593.001,628.001,582.001,367.00955.00934.00907.00
Interest Expense105.00111.0096.0093.0082.0080.0077.0073.0074.00
Unusual Expense152.00129.0083.00316.0066.00-78.0060.009.002.00
Net Income Before Taxes1,658.001,435.001,521.001,339.001,504.001,360.00842.00919.00946.00
Income Taxes218.00132.00232.0099.00250.00150.00123.00-152.00630.00
Consolidated Net Income1,440.001,303.001,289.001,240.001,254.001,210.00719.001,071.00316.00
Net Income From Continuing Operations1,440.001,303.001,289.001,240.001,254.001,210.00719.001,071.00316.00
Net Income1,440.001,303.001,289.001,240.001,254.001,210.00719.001,071.00316.00
EPS (Recurring)5.464.894.634.944.333.762.443.390.98
EPS (Basic, Before Extraordinaries)5.104.594.444.224.193.982.333.410.98
EPS (Diluted)5.084.574.434.194.183.942.303.370.97
EBITDA2,047.001,852.001,850.001,899.001,899.001,688.001,263.001,172.001,117.00
Non-Operating Income (Expense)139.00111.00107.00120.0070.00-5.0024.0067.00115.00
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense104.28129.00130.0088.48126.0081.0361.3252.5656.09
Price To Earnings Ratio35.0235.0227.0124.6133.1049.0346.1822.5766.41
Price To Sales Ratio5.316.005.824.486.067.655.974.674.29
Gross Margin53.7252.5054.6754.4353.8354.1753.1254.1254.60
Operating Margin24.0922.5124.4723.8323.1021.6317.8918.0918.46
Net Margin19.5318.7519.8018.1518.3119.1513.4720.746.43
Shares Outstanding281.97283.05285.19292.12295.26302.21306.20309.07317.71
Market Capitalization50,149.5350,149.5337,441.7130,244.7240,957.2747,675.8531,475.3723,442.2020,653.11

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue1,878.001,835.001,798.001,861.001,738.001,668.001,681.001,701.00
Cost of Goods Sold Incl. D&A836.00844.00848.00884.00838.00792.00786.00776.00
Gross Profit1,042.00991.00950.00977.00900.00876.00895.00925.00
Selling, General and Administrative Excl. Other540.00535.00575.00534.00515.00522.00507.00497.00
Research and Development120.00126.00117.00117.00111.00109.00107.00110.00
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income502.00456.00375.00443.00385.00354.00388.00428.00
Interest Expense29.0025.0024.0027.0028.0029.0028.0032.00
Unusual Expense62.0061.0018.0011.0019.0074.0016.0014.00
Net Income Before Taxes444.00408.00364.00442.00366.00260.00367.00401.00
Income Taxes82.0069.0059.008.0030.0045.0049.0050.00
Consolidated Net Income362.00339.00305.00434.00336.00215.00318.00351.00
Net Income From Continuing Operations362.00339.00305.00434.00336.00215.00318.00351.00
Net Income362.00339.00305.00434.00336.00215.00318.00351.00
EPS (Recurring)1.431.351.121.561.230.941.151.26
EPS (Basic, Before Extraordinaries)1.281.201.081.531.180.751.121.23
EPS (Diluted)1.281.201.071.531.180.751.111.22
EBITDA568.00523.00442.00514.00457.00427.00460.00497.00
Non-Operating Income (Expense)33.0038.0031.0037.0028.009.0023.0019.00
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense24.4926.8632.3920.5425.2823.7032.3926.00
Price To Earnings Ratio35.0225.4829.2934.3228.3224.7334.2327.01
Price To Sales Ratio5.314.525.385.984.824.636.665.74
Gross Margin55.4854.0152.8452.5051.7852.5253.2454.38
Operating Margin26.7324.8520.8623.8022.1521.2223.0825.16
Net Margin19.2818.4716.9623.3219.3312.8918.9220.63
Shares Outstanding281.97282.22282.70283.05283.59283.94285.23285.19
Market Capitalization50,149.5332,654.6637,858.1341,493.0632,613.5030,677.0843,273.3537,441.71

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments1,789.001,329.001,590.001,053.001,575.001,441.001,382.002,247.002,678.00
Short Term Receivables1,595.001,471.001,391.001,492.001,238.001,127.00998.00835.00801.00
Inventories1,025.00972.001,031.001,038.00830.00720.00679.00638.00575.00
Other Current Assets185.00187.00174.00195.00156.00127.00130.00128.00115.00
Total Current Assets4,594.003,959.004,186.003,778.003,799.003,415.003,189.003,848.004,169.00
Net Property, Plant & Equipment2,206.001,955.001,424.001,250.001,123.001,020.00850.00822.00757.00
Total Investments and Advances135.00178.00167.00198.00191.00164.00108.0075.00138.00
Long-Term Note Receivable3.003.003.0011.006.006.004.0019.0018.00
Intangible Assets4,918.005,024.004,435.004,773.004,956.004,433.004,700.003,464.002,968.00
Deferred Tax Assets474.00436.00284.00246.00309.00380.00410.00165.00240.00
Other Assets444.00376.00264.00276.00321.00209.00191.00148.00136.00
Total Assets12,774.0011,931.0010,763.0010,532.0010,705.009,627.009,452.008,541.008,426.00
Short Term Debt Incl. Current Port. of LT Debt348.0087.0046.0087.0052.00126.00616.000.00210.00
Accounts Payable570.00540.00418.00580.00446.00354.00354.00340.00305.00
Income Tax Payable143.00152.0073.0051.0047.0063.00292.0071.0055.00
Other Current Liabilities1,286.001,116.001,066.001,143.001,163.00924.00818.00760.00693.00
Total Current Liabilities2,347.001,895.001,603.001,861.001,708.001,467.002,080.001,171.001,263.00
Long Term Debt3,195.003,487.002,853.002,834.002,859.002,411.001,791.001,799.001,801.00
Provision for Risks Charges126.00130.00103.0097.00221.00391.00360.00239.00235.00
Deferred Tax Liabilities--38.0058.00103.0024.0031.0069.0077.00
Other Liabilities365.00521.00321.00377.00425.00461.00442.00692.00215.00
Total Liabilities6,033.006,033.004,918.005,227.005,316.004,754.004,704.003,970.003,591.00
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity6,741.005,898.005,845.005,305.005,389.004,873.004,748.004,567.004,831.00
Total Shareholders Equity6,741.005,898.005,845.005,305.005,389.004,873.004,748.004,567.004,831.00
Accumulated Minority Interest0.000.000.000.000.000.000.004.004.00
Total Equity6,741.005,898.005,845.005,305.005,389.004,873.004,748.004,571.004,835.00
Total Liabilities & Stockholders Equity12,774.0011,931.0010,763.0010,532.0010,705.009,627.009,452.008,541.008,426.00
Book Value Per Share23.8220.6820.0117.9717.8315.9115.3614.3715.00
Tangible Book Value Per Share6.443.064.831.801.431.440.163.475.79
Full-Time Employees18,10017,90018,10018,10017,00016,40016,30014,80013,500
Price to Book Ratio6.816.355.177.709.646.324.934.514.53
Return on Assets10.5511.3611.6511.8111.907.5411.903.728.43
Return on Equity20.6221.9522.2423.4523.5814.9523.006.7215.08
Return on Invested Capital13.1113.7314.2615.4114.679.8716.384.9610.31
Quick Ratio1.521.581.971.471.741.841.212.742.85
Current Ratio1.962.092.612.032.222.331.533.293.30

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income1,440.001,303.001,289.001,240.001,254.001,210.00719.001,071.00316.00
Depreciation271.00288.00257.00271.00317.00321.00308.00238.00210.00
Other Funds (Non Cash)204.00229.00186.00433.00211.0042.00190.00106.00106.00
Funds from Operations1,897.001,690.001,668.001,888.001,790.001,587.001,246.001,160.00616.00
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-288.00-131.0083.00-116.00-478.00-102.00-325.00-139.00471.00
Cash from Operating Activities1,609.001,559.001,751.001,772.001,312.001,485.00921.001,021.001,087.00
Capital Expenditures-342.00-407.00-378.00-298.00-291.00-189.00-119.00-156.00-177.00
Net Assets From Acquisitions0.004.00-862.00-51.00-52.00-546.000.00-1,412.00-516.00
Sale of Fixed Assets and Businesses-950.000.000.0050.000.001.001.000.001.00
Purchase or Sale of Investments3.008.00-5.00-3.009.00-10.00-20.00-23.00-11.00
Purchase of Investments0.000.00-5.00-8.00-13.00-22.00-20.00-23.00-11.00
Sale Or Maturity of Investments3.008.000.005.0022.0012.000.00-0.00
Other Uses-3.00-1.00-13.00-12.00-4.00-5.00-9.00-3.00-2.00
Other Sources0.002.000.004.000.000.000.000.000.00
Cash from Investing Activities-1,292.00-394.00-1,258.00-310.00-338.00-749.00-147.00-1,594.00-705.00
Cash Dividends Paid-286.00-282.00-274.00-265.00-250.00-236.00-222.00-206.00-191.00
Change in Capital Stock-318.00-363.00-1,076.00-508.00-1,081.00-733.00-446.00-669.00-366.00
Repurchase of Common Pref Stock-393.00-435.00-1,153.00-575.00-1,139.00-788.00-469.00-723.00-422.00
Sale of Common Pref Stock75.0072.0077.0067.0058.0055.0023.0054.0056.00
Proceedsfrom Stock Options0.000.000.000.000.000.00529.00777.00478.00
Issuance or Reduction of Debt, Net531.00-41.00628.00-35.0026.00349.00-49.00596.00-210.00
Change in Long Term Debt586.001.00588.000.00-9.00424.00-124.00596.00-210.00
Issuance of Long Term Debt595.004.001,188.000.00600.00841.001,293.001,298.00483.00
Reduction of Long Term Debt-9.00-3.00-600.000.00-609.00-417.00-1,417.00-702.00-693.00
Net Financing Active Other Cash Flow-22.00-29.00-30.00-122.00-67.00-76.000.00-16.00-30.00
Other Financing Activities Uses-22.00-29.00-30.00-122.00-67.00-76.000.00-16.00-30.00
Cash from Financing Activities-95.00-715.00-752.00-930.00-1,372.00-696.00-717.00-295.00-797.00
Exchange Rate Effect1.009.00-2.005.00-36.003.002.002.00-17.00
Net Change in Cash223.00459.00-261.00537.00-434.0043.0059.00-866.00-432.00
Free Cash Flow1,267.001,152.001,373.001,474.001,021.001,297.00802.00866.00910.00
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow39.9247.9534.5025.3153.8345.5754.9236.5029.29
Deferred Taxes & Investment Tax Credit--130.00-64.00-56.008.0014.0029.00-255.00-16.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments1,758.001,807.001,758.001,789.001,535.001,486.00
Short Term Receivables1,478.001,498.001,521.001,595.001,382.001,366.00
Inventories1,117.001,089.001,059.001,025.001,014.00991.00
Other Current Assets340.00369.00277.00185.00322.00365.00
Total Current Assets4,693.004,763.004,615.004,594.004,253.004,208.00
Net Property, Plant & Equipment2,321.002,280.002,267.002,206.002,145.002,094.00
Total Investments and Advances132.00138.00137.00135.00135.00138.00
Intangible Assets5,936.004,891.004,910.004,918.004,944.004,969.00
Deferred Tax Assets---474.00--
Other Assets885.00993.00884.00444.00749.00749.00
Total Assets13,967.0013,065.0012,813.0012,774.0012,226.0012,158.00
Short Term Debt Incl. Current Port. of LT Debt304.00304.00304.00348.0059.00146.00
Accounts Payable608.00615.00602.00570.00530.00517.00
Income Tax Payable---143.00--
Other Current Liabilities1,377.001,350.001,328.001,286.001,303.001,349.00
Total Current Liabilities2,289.002,269.002,234.002,347.001,892.002,012.00
Long Term Debt3,645.003,051.003,050.003,195.003,350.003,349.00
Provision for Risks Charges151.00127.00130.00126.00147.00126.00
Other Liabilities519.00496.00491.00365.00467.00535.00
Total Liabilities6,604.005,943.005,905.006,033.005,856.006,022.00
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity7,363.007,122.006,908.006,741.006,370.006,136.00
Total Shareholders Equity7,363.007,122.006,908.006,741.006,370.006,136.00
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity7,363.007,122.006,908.006,741.006,370.006,136.00
Total Liabilities & Stockholders Equity13,967.0013,065.0012,813.0012,774.0012,226.0012,158.00
Book Value Per Share26.1125.2424.4423.8222.4621.61
Tangible Book Value Per Share5.067.917.076.445.034.11
Full-Time Employees---18,10018,000-
Price to Book Ratio6.814.735.626.525.315.09
Return on Assets11.0011.2110.4310.5510.5110.13
Return on Equity20.9721.3319.9520.6219.8818.88
Return on Invested Capital3.293.333.064.373.462.27
Quick Ratio1.561.621.591.521.711.60
Current Ratio2.052.102.071.962.252.09

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income362.00339.00305.00434.00336.00215.00
Depreciation66.0067.0067.0071.0072.0073.00
Other Funds (Non Cash)53.0050.0051.0050.0043.0087.00
Funds from Operations501.00488.00448.00460.00444.00357.00
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital18.00-211.00-180.0085.00-82.00-136.00
Cash from Operating Activities519.00277.00268.00545.00362.00221.00
Capital Expenditures-80.00-76.00-93.00-93.00-103.00-114.00
Net Assets From Acquisitions0.000.000.000.004.000.00
Sale of Fixed Assets and Businesses-950.000.000.000.00-4.000.00
Purchase or Sale of Investments0.000.000.003.005.000.00
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.003.005.000.00
Other Uses-2.00-1.000.000.000.000.00
Other Sources0.000.000.000.002.000.00
Cash from Investing Activities-1,032.00-77.00-93.00-90.00-96.00-114.00
Cash Dividends Paid-72.00-72.00-72.00-70.00-71.00-70.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock-47.00-67.00-121.00-83.00-56.00-164.00
Repurchase of Common Pref Stock-78.00-68.00-152.00-95.00-85.00-165.00
Sale of Common Pref Stock31.001.0031.0012.0029.001.00
Proceedsfrom Stock Options0.000.000.000.000.000.00
Issuance or Reduction of Debt, Net592.00-3.00-2.00-56.00-88.00130.00
Change in Long Term Debt592.00-3.00-2.00-1.00-1.000.00
Issuance of Long Term Debt595.000.000.000.000.000.00
Reduction of Long Term Debt-3.00-3.00-2.00-1.00-1.000.00
Net Financing Active Other Cash Flow-2.00-2.00-27.009.00-4.00-12.00
Other Financing Activities Uses-2.00-2.00-27.009.00-4.00-12.00
Cash from Financing Activities471.00-144.00-222.00-200.00-219.00-116.00
Exchange Rate Effect-7.00-7.0016.00-1.001.0028.00
Net Change in Cash-49.0049.00-31.00254.0048.0019.00
Free Cash Flow439.00201.00175.00452.00259.00107.00
Price to Free Cash Flow39.9240.7753.5447.7840.5033.62

Revenue breakdown

Product2024: 4.67B 2025: 4.94B
Service, Other2024: 1.84B 2025: 2.00B
Americas2024: 2.57B 2025: 2.81B
Asia Pacific2024: 2.17B 2025: 2.22B
Europe2024: 1.77B 2025: 1.92B
Agilent CrossLab2024: 2.75B 2025: 2.91B
Applied Markets2024: 1.30B 2025: 1.31B
Life Sciences and Diagnostics Markets2024: 2.47B 2025: 2.73B

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-301.74%4.9M281.0M2.22M
2026-10-151.79%5.0M281.0M2.25M
2026-09-301.87%5.2M281.0M2.27M
2026-09-151.81%5.1M281.0M2.19M
2026-08-312.02%5.7M281.0M2.23M
2026-08-141.84%5.2M281.5M2.28M
2026-07-312.04%5.7M281.5M2.41M
2026-07-152.68%7.5M281.5M2.36M
2026-06-301.89%5.3M281.5M2.27M
2026-06-152.01%5.7M281.3M2.22M
2026-05-291.85%5.2M281.5M2.27M
2026-05-151.95%5.5M281.7M2.23M
2026-04-301.71%4.8M281.8M2.23M
2026-04-151.59%4.5M281.8M2.22M
2026-03-311.61%4.5M281.8M2.30M
2026-03-131.70%4.8M281.8M2.25M
2026-02-271.62%4.6M281.8M2.16M
2026-02-131.52%4.3M282.1M2.07M
2026-01-301.52%4.3M281.5M1.99M
2026-01-151.41%4.0M282.1M1.92M

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call60.00116120.10.004.5130.000.000.993-0.0950.006
call65.00111115.10.004.2510.000.000.992-0.0950.006
call70.00106110.354.103.9687.000.000.991-0.0950.007
call75.00101105.20.003.6670.000.000.991-0.0950.007
call80.0096.40100.155.003.4613.000.000.990-0.0950.008
call85.0091.4095.100.003.2320.000.000.989-0.0940.008
call90.0086.0090.200.003.0170.000.000.988-0.0940.009
call95.0081.2085.100.002.8130.000.000.988-0.0940.009
call10076.2080.1061.452.6203.000.000.987-0.0930.010
call10571.2074.8029.002.2891.000.000.986-0.0930.011
call11066.5070.1033.262.2332.000.000.984-0.0920.011
call11561.3065.1024.942.0905.000.000.983-0.0910.012
call12057.0059.9029.131.8286.000.000.982-0.0900.013
call12552.0054.9048.951.67840.000.000.980-0.0890.014
call13047.0049.4048.901.41166.000.000.978-0.0880.015
call13542.0044.9040.651.38670.000.000.976-0.0870.017
call14037.0040.0036.371.26512.000.000.973-0.0850.018
call14531.9034.5032.351.0331450.000.969-0.0840.020
call15026.9030.2027.801.0221120.000.965-0.0810.023
call15522.2024.7019.900.80887.000.000.948-0.0970.031
call16017.4020.0015.550.7192250.000.927-0.1080.040
call16513.1015.4013.680.62972.005.000.855-0.1670.067
call1708.7011.209.800.56220495.000.747-0.2230.093
call1755.607.306.300.4891,22798.000.609-0.2570.112
call1803.104.303.310.4467567.000.451-0.2570.116
call1851.102.101.630.40466216.000.298-0.2180.101
call1900.601.150.850.4171,2168.000.181-0.1670.077
call1950.001.000.410.49586.007.000.142-0.1680.065
call2000.050.550.250.5011330.000.085-0.1170.045
put60.000.002.150.103.5387.000.00-0.016-0.2090.012
put65.000.002.150.453.2964.000.00-0.018-0.2080.013
put70.000.002.150.052.72312.000.00-0.011-0.1150.009
put75.000.002.151.732.5411.000.00-0.012-0.1140.009
put80.000.002.150.252.3751.000.00-0.013-0.1140.010
put85.000.002.150.052.2086.000.00-0.014-0.1130.010
put90.000.002.150.052.06198.000.00-0.015-0.1130.011
put95.000.002.150.001.9200.000.00-0.016-0.1120.012
put1000.002.150.031.7813.000.00-0.017-0.1100.012
put1050.002.151.001.5614.000.00-0.014-0.0840.011
put1100.002.150.061.43813.000.00-0.015-0.0830.011
put1150.002.001.111.32028.000.00-0.017-0.0810.012
put1200.002.150.451.2072.000.00-0.018-0.0800.013
put1250.001.400.051.09727.000.00-0.020-0.0780.014
put1300.000.800.100.99169.000.00-0.022-0.0770.015
put1350.001.000.010.88844.000.00-0.024-0.0750.017
put1400.000.450.050.7881170.00-0.027-0.0730.018
put1450.000.750.150.6901560.00-0.031-0.0700.020
put1500.000.250.040.5931322.00-0.035-0.0680.023
put1550.050.350.150.5331371.00-0.052-0.0830.031
put1600.150.450.700.4603692.00-0.073-0.0930.040
put1650.600.850.600.4281,2881.00-0.145-0.1510.067
put1700.951.651.400.4031,52024.00-0.253-0.2080.093
put1751.703.203.400.3955724.00-0.391-0.2400.112
put1804.305.705.220.3984750.00-0.548-0.2400.116
put1857.309.400.000.4390.000.00-0.702-0.2010.101
put19011.5013.2020.700.4317.000.00-0.819-0.1490.077
put19516.1018.600.000.5880.000.00-0.858-0.1490.065
put20020.8023.400.000.6590.000.00-0.915-0.0980.045

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-09-23EFFECTEffectiveness filing by commission orderSEC
2026-09-23424B3SEC
2026-09-104Statement of changes in beneficial ownership of securities2026-09-08SEC
2026-09-103Initial statement of beneficial ownership of securities2026-09-04SEC
2026-09-094Statement of changes in beneficial ownership of securities2026-09-04SEC
2026-09-088-KCurrent report2026-09-02SEC
2026-09-04144Filing for proposed sale of securities under Rule 144.SEC
2026-09-01S-4Registration statement for securities to be issued in business combination transactionsSEC
2026-09-01S-3ASRAutomatic shelf registration statement of securities of well-known seasoned issuersSEC
2026-09-0110-QQuarterly report pursuant to Section 13 or 15(d)2026-07-31SEC
2026-08-268-KCurrent report2026-08-26SEC
2026-06-294Statement of changes in beneficial ownership of securities2026-06-26SEC
2026-06-258-KCurrent report2026-06-25SEC
2026-06-053Initial statement of beneficial ownership of securities2026-06-02SEC
2026-06-054Statement of changes in beneficial ownership of securities2026-06-03SEC
2026-06-024Statement of changes in beneficial ownership of securities2026-05-29SEC
2026-06-0110-QQuarterly report pursuant to Section 13 or 15(d)2026-04-30SEC
2026-05-29144Filing for proposed sale of securities under Rule 144.SEC
2026-05-29SDSpecialized Disclosure ReportSEC
2026-05-278-KCurrent report2026-05-20SEC
2026-05-214Statement of changes in beneficial ownership of securities2026-05-19SEC
2026-05-124Statement of changes in beneficial ownership of securities2026-05-08SEC
2026-05-083Initial statement of beneficial ownership of securities2026-05-04SEC
2026-05-048-KCurrent report2026-05-04SEC
2026-04-29SCHEDULE 13GSEC
2026-04-28SCHEDULE 13GSEC
2026-04-068-K/A2026-03-31SEC
2026-04-038-KCurrent report2026-03-31SEC
2026-04-024Statement of changes in beneficial ownership of securities2026-03-31SEC
2026-03-26SCHEDULE 13G/ASEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090095.97K1
2026-080000
2026-070000
2026-060000
2026-0500216.67K1
2026-040000
2026-030000
2026-020000
2026-010000
2025-1200389.51K1
2025-11002.47M3

Institutional holders

Manager% owned
BlackRock, Inc.9.06%
VANGUARD CAPITAL MANAGEMENT LLC6.53%
VANGUARD PORTFOLIO MANAGEMENT LLC5.11%
STATE STREET CORP4.55%
MASSACHUSETTS FINANCIAL SERVICES CO /MA/3.54%
T. Rowe Price Investment Management, Inc.2.75%
GEODE CAPITAL MANAGEMENT, LLC2.72%
WELLINGTON MANAGEMENT GROUP LLP2.64%
Bank of New York Mellon Corp2.50%
FMR LLC2.43%

Funds

Fund% owned
VANGUARD INTERMEDIATE-TERM INVESTMENT-GRADE FUND12.07%
First Trust Enhanced Short Maturity ETF8.85%
VANGUARD SHORT-TERM INVESTMENT-GRADE FUND8.32%
VANGUARD INTERMEDIATE-TERM CORPORATE BOND INDEX FUND7.94%
PGIM Ultra Short Bond ETF7.36%
Invesco Ultra Short Duration ETF7.08%
VANGUARD INSTITUTIONAL INTERMEDIATE-TERM BOND FUND5.21%
Baird Aggregate Bond Fund4.96%
T. Rowe Price Short-Term Bond Fund, Inc.4.83%
Invesco Conservative Income Fund3.54%

OakChart. A. Cached 15 minutes.